you are here: Home News Novartis India

Novartis India

Novartis India Standalone June 2025 Net Sales at Rs 87.55 crore, down 5.14% Y-o-Y
Stocks to Watch Today: Indiqube Spaces, GNG Electronics, Dilip Buildcon, GMR Airports, Ask Automotive, GE Vernova, IGI India, L&T in focus on 30 July
Novartis India Standalone December 2024 Net Sales at Rs 93.00 crore, up 10.01% Y-o-Y
Novartis India Standalone September 2024 Net Sales at Rs 87.10 crore, up 10.59% Y-o-Y
Novartis India Standalone June 2024 Net Sales at Rs 92.29 crore, up 1.87% Y-o-Y
Novartis India Standalone March 2024 Net Sales at Rs 81.17 crore, up 6.62% Y-o-Y
Novartis explores potential transfer of listed business ownership in India
Dr Reddy's scales 52-week high on buzz over plans to acquire Novartis' India arm
Novartis AG announces strategic review of Novartis India
Novartis India Standalone December 2023 Net Sales at Rs 84.54 crore, up 5.45% Y-o-Y
Novartis India Standalone September 2023 Net Sales at Rs 78.76 crore, down 22.42% Y-o-Y
Novartis India falls 3% on kidney transplant drug shortage
Novartis India facing shortage of drug ‘Simulect’ used on kidney transplant patients
Novartis India Standalone June 2023 Net Sales at Rs 90.60 crore, down 25.07% Y-o-Y
Fit to Lead | Novartis India’s Amitabh Dube: ‘Focus keeps you on the right track, discipline helps you to be consistent’
Novartis India Standalone March 2023 Net Sales at Rs 76.13 crore, down 22.57% Y-o-Y
Novartis India Standalone December 2022 Net Sales at Rs 80.17 crore, down 18.99% Y-o-Y
Novartis India Standalone December 2022 Net Sales at Rs 80.17 crore, down 18.99% Y-o-Y
Cancer therapy shifting from patient-fitting treatment to treatment-fitting patient model: Novartis India MD
Novartis India Standalone September 2022 Net Sales at Rs 101.52 crore, down 2.83% Y-o-Y
Novartis India Standalone September 2022 Net Sales at Rs 101.52 crore, down 2.83% Y-o-Y
Novartis India Standalone March 2022 Net Sales at Rs 98.32 crore, down 0.98% Y-o-Y
Novartis India transfers sales and distribution to Dr Reddy’s Labs, to axe 400 employees
Novartis India Standalone December 2021 Net Sales at Rs 98.96 crore, up 5.53% Y-o-Y
Novartis India Standalone June 2021 Net Sales at Rs 98.11 crore, up 6.11% Y-o-Y

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Novartis India

Novartis India Standalone June 2025 Net Sales at Rs 87.55 crore, down 5.14% Y-o-Y

Stocks to Watch Today: Indiqube Spaces, GNG Electronics, Dilip Buildcon, GMR Airports, Ask Automotive, GE Vernova, IGI India, L&T in focus on 30 July

Novartis India Standalone December 2024 Net Sales at Rs 93.00 crore, up 10.01% Y-o-Y

Novartis India Standalone September 2024 Net Sales at Rs 87.10 crore, up 10.59% Y-o-Y

Novartis India Standalone June 2024 Net Sales at Rs 92.29 crore, up 1.87% Y-o-Y

Novartis India Standalone March 2024 Net Sales at Rs 81.17 crore, up 6.62% Y-o-Y

Novartis explores potential transfer of listed business ownership in India

Dr Reddy's scales 52-week high on buzz over plans to acquire Novartis' India arm

Novartis AG announces strategic review of Novartis India

Novartis India Standalone December 2023 Net Sales at Rs 84.54 crore, up 5.45% Y-o-Y

Novartis India Standalone September 2023 Net Sales at Rs 78.76 crore, down 22.42% Y-o-Y

Novartis India falls 3% on kidney transplant drug shortage

Novartis India facing shortage of drug ‘Simulect’ used on kidney transplant patients

Novartis India Standalone June 2023 Net Sales at Rs 90.60 crore, down 25.07% Y-o-Y

Fit to Lead | Novartis India’s Amitabh Dube: ‘Focus keeps you on the right track, discipline helps you to be consistent’

Novartis India Standalone March 2023 Net Sales at Rs 76.13 crore, down 22.57% Y-o-Y

Novartis India Standalone December 2022 Net Sales at Rs 80.17 crore, down 18.99% Y-o-Y

Novartis India Standalone December 2022 Net Sales at Rs 80.17 crore, down 18.99% Y-o-Y

Cancer therapy shifting from patient-fitting treatment to treatment-fitting patient model: Novartis India MD

Novartis India Standalone September 2022 Net Sales at Rs 101.52 crore, down 2.83% Y-o-Y

Novartis India Standalone September 2022 Net Sales at Rs 101.52 crore, down 2.83% Y-o-Y

Novartis India Standalone March 2022 Net Sales at Rs 98.32 crore, down 0.98% Y-o-Y

Novartis India transfers sales and distribution to Dr Reddy’s Labs, to axe 400 employees

Novartis India Standalone December 2021 Net Sales at Rs 98.96 crore, up 5.53% Y-o-Y

Novartis India Standalone June 2021 Net Sales at Rs 98.11 crore, up 6.11% Y-o-Y